Alexander F. Equord-Von Hammerstein
Robert Koch Str. 40
Goettingen, NI 37075, Germany
Goettingen, NI 37075, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
Correction: Comparison of real-world efficacy and safety of nivolumab plus ipilimumab or pembrolizumab combined with platinum-based chemotherapy as first-line treatment for advanced non-small cell lung cancer in a German population.
Journal: Cancer immunology, immunotherapy : CII
Published: April 06, 2026
The abscopal effect in metastatic lung cancer: a retrospective analysis of combined radiotherapy and immunotherapy.
Journal: Clinical & experimental metastasis
Published: May 05, 2025
Impact of radiation dose on immune cells (EDIC) on oncologic outcome in small cell lung cancer (SCLC).
Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Published: May 02, 2025
Proteasome inhibition as a potential therapeutic target in thymic cancer.
Journal: Cell death & disease
Published: January 08, 2025
Expression and prongostic impact of galectin-7 in human lung cancer.
Journal: Medicine
Published: October 28, 2024
Metabolomic Profiling of Large Extracellular Vesicles in Patients Suffering from Small Cell Lung Cancer.
Journal: Anticancer research
Published: August 06, 2024
Outcomes of Multimodal Treatment in Elderly Patients with Localized Non-Small Lung Cancer from a Radiation Oncology Point of View: Special Focus on Low-Dose Cisplatin.
Journal: Cancers
Published: December 07, 2023
Expression and prognostic impact of DNA-PK in human lung cancer.
Journal: Medicine
Published: March 02, 2023
Proteomic analysis identifies argininosuccinate synthetase 1 and special AT-rich sequence binding protein 1 as reliable markers for the immunohistochemical distinction between WHO types A and B3 thymomas.
Journal: Histopathology
Published: February 14, 2023
Last Updated: 09/26/2026